Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Iclusig price?

See the DrugPatentWatch profile for Iclusig

How much does Iclusig cost?

The price of Iclusig (ponatinib) can vary depending on several factors, including the country, location, and patient's insurance coverage.

[1] According to Drugs.com, Iclusig's average retail price in the United States is around $63,000 per year [1].

[2] However, the actual cost of Iclusig for patients may be lower due to their insurance coverage, patient assistance programs, or co-pay assistance.

What factors affect the cost of Iclusig?

The cost of Iclusig can be influenced by several factors, including:

* The patient's insurance coverage and the level of coverage
* The patient's age, health, and medical history
* The dosage and frequency of administration
* The pharmacy's location and pricing
* Any out-of-pocket costs, such as co-pays or deductibles

Can I get financial assistance for Iclusig?

Yes, there are several options available to help patients with the cost of Iclusig, including:

* Patient assistance programs (PAPs) offered by the manufacturer, ARIAD Pharmaceuticals
* Co-pay assistance programs
* Non-profit organizations, such as the Iclusig Patient Assistance Program
* State and federal assistance programs

What is the typical insurance coverage for Iclusig?

Insurance coverage for Iclusig can vary widely depending on the insurance plan and the patient's circumstances. However, many insurance plans, including Medicare and Medicaid, cover Iclusig for eligible patients [3].

Can biosimilars reduce the cost of Iclusig?

Currently, there are no biosimilars approved in the United States for Iclusig. However, if a biosimilar were to be approved, it could potentially reduce the cost of Iclusig for patients.

When does the patent for Iclusig expire?

According to DrugPatentWatch.com, the patent for Iclusig expires in 2037 [4]. This means that the manufacturer, ARIAD Pharmaceuticals, will lose its exclusive rights to market the drug on its own, potentially leading to increased competition and lower prices.

Citations:

[1] Drugs.com - Iclusig price information

[2] ARIAD Pharmaceuticals - Iclusig patient assistance program

[3] Medicare.gov - Iclusig coverage information

[4] DrugPatentWatch.com - Iclusig patent information

Sources:

1. Drugs.com
2. ARIAD Pharmaceuticals
3. Medicare.gov
4. DrugPatentWatch.com



Other Questions About Iclusig :

Can iclusig be used for t315i mutations? What are the benefits of Iclusig?